Congestive heart failure: Increased cardiac and extracardiac atrial natriuretic peptide gene expression

Cardiovascular Research

Volumn 32, Issue 5, 1996, Pages 909-919

  Poulos, John E ^a,c   Gower Jr , William R ^a   Sullebarger, Thompson ^a   Fontanet, Hector L ^a   Vesely, David L ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Saint Louis Medical Center   (United States)

Author keywords

atrial natriuretic factor; gene expression; heart failure; rat, A V fistular model

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GENE EXPRESSION; HEART HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030296645     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00138-1     Document Type: Article

References (37)

1. [1] Vesely DL. Atrial Natriuretic Hormones. Englewood Cliffs, NJ: Prentice Hall Inc., 1992;1-256.
2. [2] Vesely DL, Douglass MA, Dietz JR, Giordano AT, McCormick MT, Rodriguez-Paz G, Schocken DD. Negative feedback of atrial natriuretic peptides. J Clin Endocrinol Metab 1994;78:1128-1134.
3. [3] Vesely DL, Douglass MA, Dietz JR, Gower WR Jr, McCormick MT, Rodriguez-Paz G, Schocken DD. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994;90:1129-1140.
4. 2-terminus are natriuretic and/or kaliuretic. Am J Physiol 1990;258:F1401-F1408.
5. [5] Winters CJ, Baker BJ, Dinh H, Sallman AL, Rico DM, Vesely DL. Prohormone atrial natriuretic peptides 1-98 and 31-67 increase with exercise in congestive heart failure patients. Am J Med Sci 1989;298:377-382.
6. [6] Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL. The N-terminus and a 4000 molecular weight peptide from the midportion of the atrial natriuretic factor prohormone each circulate in man and increase in congestive heart failure. Circulation 1989;80:438-449.
7. [7] Arendt R, Gerbes A, Ritter D, Stangl E. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertension 1986;4(Suppl 2):131-135.
8. [8] Criteria Committee of the New York Heart Association, Inc. Diseases of the Heart and Blood Vessels, Nomenclature and Criteria for Diagnosis, ed 6. Boston: Little, Brown and Co., 1964.
9. [9] Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N-terminal atrial natriuretic peptide as a marker of symptomless left-ventricular dysfunction. Lancet 1993;341:1105-1109.
10. [10] Tsuchimochi H, Yazaki Y, Ohno H, Takanashi R, Takaku F. Ventricular expression of atrial natriuretic peptide. Lancet 1987;2:336-337.
11. [11] Edwards BS, Ackermann DM, Lee ME, Reeder GS, Wold LE, Burnett JC. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest 1988;81:82-86.
12. [12] Poulos JE, Gower WR Jr, Fontanet HL, Kalmus GW, Vesely DL. 1995 Cirrhosis with ascites: Increased atrial natriuretic peptide gene expression in rat ventricle. Gastroenterology 1995;108:1496-1503.
13. [13] Gower WR Jr, Dietz JR, Vesely DL, Finley CL, Skolnick KA, Fabri PJ, Chalfont CE. Atrial natriuretic peptide gene expression in the rat gastrointestinal tract. Biochem Biophys Res Commun 1994;202:562-570.
14. [14] Pinsky WW, Lewis RM, Hartley CJ, Entman ML. Permanent changes of ventricular contractility and compliance in chronic volume overload. Am J Physiol 1979;237(Heart Circ Physiol 6):H575-H583.
15. [15] Villarreal DR, Freeman RH, Davis JO, Verburg KM, Vari RC. Atrial natriuretic factor secretion in dogs with experimental high-output heart failure. Am J Physiol 1987;252(Heart Circ Physiol 21):H692-H696.
16. [16] Villarreal D, Freeman RH, Brands MW. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure. Am J Physiol 1989;257(Heart Circ Physiol 26):H739-H745.
17. [17] Habibullah AA, Villarreal D, Freeman RH, Dietz JR, Vesely DL, Simmons JC. Infusion of atrial natriuretic factor prohormone peptides in dogs with experimental heart failure. Clin Exp Pharmacol Physiol 1995;22:130-135.
18. [18] Chou SY, Faubert PF, Epstein EM, Blackstock DG, Porush JG. Inner medullary hemodynamics in dogs with aortocaval fistula Am J Physiol 1987;252(Renal Fluid Electrolyte Physiol 21):F724-F732.
19. [19] Gower WR Jr, Chiou S, Skolnick KA, Vesely DL. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994;15:861-867.
20. [20] Liu Z, Hilbelink DR, Crockett WB, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas: 1. Developing and established hypertrophy. Circ Res 1991;69:52-58.
21. [21] Fontanet HL, D'Ambra P, Clark L, Sullenbarger JT. The use of high resolution echocardiography to characterize in vivo the progression of volume overload remodeling into heart failure. J Am Soc Echocardiography 1994;7:S2.
22. [22] Zimmer HG. Measurement of left ventricular hemodynamic parameters in closed-chest rats under control and various pathophysiologic conditions. Basic Res Cardiol 1983;78:77-84.
23. [23] Zimmer HG, Zierhut W, Seesko RC, Varchamp AE. Right heart catherization in rats with pulmonary hypertension and right ventricular hypertrophy. Basic Res Cardiol 1988;83:48-57.
24. [24] Vesely DL, Norsk P, Winters CJ, Rico DM, Sallman AL, Epstein M. Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans. Proc Soc Exp Biol Med 1989;192:230-235.
25. [25] Vesely DL, Gower WR Jr, Giordano AT, Friedl FE. Atrial natriuretic peptides in the heart and hemolymph of the oyster, Crassostrea virginica: A comparison with vertebrates. Comp Biochem Physiol 1993;106B:535-546.
26. [26] Gardner DG, Vlasuk GP, Baxter JD, Fiddes JC, Lewicki JA. Identification of atrial natriuretic factor gene transcription in the central nervous system of the rat. Proc Natl Acad Sci USA 1987;84:2175-2179.
27. [27] Yamanaka M, Greenberg B, Johnson L, et al. Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor. Nature 1984;309:719-722.
28. [28] Nudel U, Zakut R, Shani M, Neuman S, Levey Z, Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 1983;11:1759-1771.
29. [29] Vesely DL, Gower WR Jr, Giordano AT. Atrial natriuretic peptides throughout the plant kingdom: Enhancement of solute flow by peptides from the N-terminus of the atrial natriuretic factor prohormone. Am J Physiol 1993;265:E465-E477.
30. [30] Vesely DL, Winters CJ, Sallman AL. Atrial natriuretic factor in the pleural fluid of congestive heart failure patients. Chest 1989;95:1107-1109.
31. [31] Vesely DL, Winters CJ, Sallman AL. The N-terminus of the atrial natriuretic factor prohormone in the pleural fluid of congestive heart failure patients. Chest 1990;97:1295-1298.
32. [32] Vesely DL, Winters CJ. Atrial natriuretic factor in the ascitic fluid of cirrhotic patients. J Med 1989;20:208-216.
33. [33] Abassi ZA, Kotob S, Golomb E, Pieruzzi F, Keiser HR. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. Hypertension 1995;25:1178-1184.
34. [34] MacCall D, O'Rourke RA. Congestive heart failure. In Stein JH, ed. Internal Medicine. Boston: Little Brown and Co., 1990;84-96.
35. [35] Dietz JR, Nazian SJ, Vesely DL. Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distention. Am J Physiol 1991;260:H1774-H1778.
36. [36] Ngo L, Wyeth RP, Bissett JK, et al. Prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126 increase in proportion to right ventricular pacing rate. Am Heart J 1989;117:385-390.
37. [37] Ackerman BH, Wyeth RP, Vesely DL, Ngo WL, Bissett JK, Winters CJ, Sallman AL. Pharmacokinetic characterization of the post-distribution phase of prohormone atrial natriuretic peptide amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs. J Clin Pharmacol 1992;32:415-421.